Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-10-04 4:19 pm Sale | 13D | AMYLYX PHARMACEUTICALS INC AMLX | Morningside Venture Investments Ltd | 2,313,227 3.43% | -2,305,619 (-49.92%) | View |
| 2023-09-19 9:30 pm Purchase | 13G | NEWAMSTERDAM PHARMA CO NV SHS NAMS | Morningside Venture Investments Ltd | 4,060,923 4.93% | 4,060,923 (New Position) | View |
| 2023-08-17 5:15 pm Sale | 13D | AMYLYX PHARMACEUTICALS INC AMLX | Morningside Venture Investments Ltd | 4,618,846 6.86% | -4,000,000 (-46.41%) | View |
| 2023-08-17 5:14 pm Unchanged | 13D | KEZAR LIFE SCIENCES INC KZR | Morningside Venture Investments Ltd | 6,254,545 8.6% | 0 (Unchanged) | View |
| 2023-07-25 4:01 pm Sale | 13D | GREENLIGHT BIOSCIENCES HLDGS P GRNA | Morningside Venture Investments Ltd | 0 0% | -16,919,155 (Position Closed) | View |
| 2023-06-07 5:28 pm Purchase | 13D | GREENLIGHT BIOSCIENCES HLDGS P GRNA | Morningside Venture Investments Ltd | 16,919,155 11.15% | 3,061,224 (+22.09%) | View |
| 2023-04-03 4:43 pm Sale | 13D | AMYLYX PHARMACEUTICALS INC AMLX | Morningside Venture Investments Ltd | 8,618,846 12.92% | -683,296 (-7.35%) | View |
| 2023-02-23 4:17 pm Unchanged | 13D | LUMIRADX LTD SHS LTD LMDX | Morningside Venture Investments Ltd | 54,127,838 30.2% | 0 (Unchanged) | View |
| 2023-02-14 4:04 pm Purchase | 13D | LUMIRADX LTD SHS LTD LMDX | Morningside Venture Investments Ltd | 54,127,838 30.2% | 34,632,690 (+177.65%) | View |
| 2022-12-02 4:05 pm Purchase | 13G | FRAZIER LIFESCIENCES ACQ CORP FLAC | Morningside Venture Investments Ltd | 5,065,846 6.21% | 5,065,846 (New Position) | View |
| 2022-09-30 4:05 pm Sale | 13D | AMYLYX PHARMACEUTICALS INC AMLX | Morningside Venture Investments Ltd | 9,302,142 15.89% | -1,376,666 (-12.89%) | View |
| 2022-02-16 4:00 pm Sale | 13G | ATEA PHARMACEUTICALS INC AVIR | Morningside Venture Investments Ltd | 0 0% | -6,634,956 (Position Closed) | View |
| 2022-02-14 4:18 pm Purchase | 13G | LUMIRADX LTD SHS LTD LMDX | Morningside Venture Investments Ltd | 19,495,148 40.9% | 19,495,148 (New Position) | View |
| 2022-02-14 4:07 pm Purchase | 13D | GREENLIGHT BIOSCIENCES HLDGS P GRNA | Morningside Venture Investments Ltd | 13,857,931 11.3% | 13,857,931 (New Position) | View |
| 2022-02-14 4:05 pm Purchase | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Morningside Venture Investments Ltd | 12,806,342 13.2% | 250,000 (+1.99%) | View |
| 2022-01-25 4:54 pm Purchase | 13D | AMYLYX PHARMACEUTICALS INC AMLX | Morningside Venture Investments Ltd | 10,678,808 18.9% | 10,678,808 (New Position) | View |
| 2021-11-22 07:51 am Purchase | 13D | STEALTH BIOTHERAPEUTICS CORP S MITO | Morningside Venture Investments Ltd | 540,133,192 66.5% | 540,133,192 (New Position) | View |
| 2021-02-16 4:19 pm Purchase | 13G | ATEA PHARMACEUTICALS INC AVIR | Morningside Venture Investments Ltd | 6,634,956 8.03% | 6,634,956 (New Position) | View |
| 2021-02-16 4:17 pm Purchase | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Morningside Venture Investments Ltd | 12,556,342 15.8% | 540,540 (+4.50%) | View |
| 2021-02-16 4:15 pm Unchanged | 13D | KEZAR LIFE SCIENCES INC KZR | Morningside Venture Investments Ltd | 6,254,545 13.5% | 0 (Unchanged) | View |